Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saadettin Kilickap

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
JAMA|April 9, 2009
Risk of venous thromboembolism with bevacizumab in cancer patientsSaadettin Kilickap, Cagatay Arslan
American Journal of Clinical Oncology|June 8, 2010
The effect on prognosis of postoperative CA 19-9 level in patients with pancreatic cancerSaadettin Kilickap, Cagatay Arslan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?Saadettin Kilickap, Deniz Tural
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Paclitaxel, not bevacizumab, was primarily responsible for the favorable effects seen in the RIBBON-2 trialAltug Kesikli, Saadettin Kilickap
American Journal of Clinical Oncology|April 7, 2009
Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative diseaseSaadettin Kilickap, Cagatay Arslan
The New England Journal of Medicine|May 25, 2007
Images in clinical medicine. The sign of Leser-TrélatSaadettin Kilickap, Basak Yalcin
The New England Journal of Medicine|February 19, 2015
First-line crizotinib in ALK-positive lung cancerDeniz Tural, Saadettin Kilickap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Mortality in colorectal cancer and use of statinsDeniz Tural, Saadettin Kilickap
Protein and Peptide Letters|November 23, 2013
Therapeutic proteins in tumors and targeted therapeutic agents for cancer patientsS Altug Kesikli, Saadettin Kilickap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Bevacizumab, bleeding, thrombosis, and warfarinSaadettin Kilickap, Huseyin Abali, Ismail Celik
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
JAMA|April 9, 2009
Risk of venous thromboembolism with bevacizumab in cancer patientsSaadettin Kilickap, Cagatay Arslan
American Journal of Clinical Oncology|June 8, 2010
The effect on prognosis of postoperative CA 19-9 level in patients with pancreatic cancerSaadettin Kilickap, Cagatay Arslan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?Saadettin Kilickap, Deniz Tural
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Paclitaxel, not bevacizumab, was primarily responsible for the favorable effects seen in the RIBBON-2 trialAltug Kesikli, Saadettin Kilickap
American Journal of Clinical Oncology|April 7, 2009
Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative diseaseSaadettin Kilickap, Cagatay Arslan
The New England Journal of Medicine|May 25, 2007
Images in clinical medicine. The sign of Leser-TrélatSaadettin Kilickap, Basak Yalcin
The New England Journal of Medicine|February 19, 2015
First-line crizotinib in ALK-positive lung cancerDeniz Tural, Saadettin Kilickap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Mortality in colorectal cancer and use of statinsDeniz Tural, Saadettin Kilickap
Protein and Peptide Letters|November 23, 2013
Therapeutic proteins in tumors and targeted therapeutic agents for cancer patientsS Altug Kesikli, Saadettin Kilickap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Bevacizumab, bleeding, thrombosis, and warfarinSaadettin Kilickap, Huseyin Abali, Ismail Celik
Pageof 16